Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-03

Clinical Trial Update: Bioequivalence Study for Benzyl Alcohol Lotion 5%. [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study for Benzyl Alcohol Lotion 5% completed for head lice; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benzyl Alcohol Lotion 5% (Benzyl Alcohol Lotion 5%)

Snippet

Sponsor: Akorn, Inc. | Conditions: Head Lice | Phase 3 | Status: COMPLETED | Results posted: 2020-09-03